These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study. Tefas C; Ciobanu L; Tanțău M; Moraru C; Socaciu C Bosn J Basic Med Sci; 2020 May; 20(2):262-270. PubMed ID: 31368421 [TBL] [Abstract][Full Text] [Related]
7. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease. Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201 [TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease. Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807 [TBL] [Abstract][Full Text] [Related]
9. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease. Yılmaz B; Köklü S; Yüksel O; Arslan S World J Gastroenterol; 2014 Aug; 20(31):10916-20. PubMed ID: 25152594 [TBL] [Abstract][Full Text] [Related]
12. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease. Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875 [TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience. Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916 [TBL] [Abstract][Full Text] [Related]
14. Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity. Yeşil A; Gönen C; Senateş E; Paker N; Gökden Y; Koçhan K; Erdem ED; Gündüz F Dig Dis Sci; 2013 Sep; 58(9):2587-93. PubMed ID: 23633156 [TBL] [Abstract][Full Text] [Related]
15. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis. Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187 [TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. Dumitrescu G; Mihai C; Dranga M; Prelipcean CC World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037 [TBL] [Abstract][Full Text] [Related]
18. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease. Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease. Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573 [TBL] [Abstract][Full Text] [Related]